Back

Outcomes after cavotricuspid isthmus ablation: predictors of new-onset atrial fibrillation and stroke according to anticoagulation strategy

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Oral anticoagulation in atrial fibrillation Oral Anticoagulation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Jose Carlos Villoria Martin

Juan Ramon Jimenez University Hospital, Huelva (Spain)

4 More presentations in this session

Presentation thumbnail
Impact of kidney function on cardiovascular outcome in patients with device-detected atrial fibrillation in NOAH-AFNET 6
Professor A. Goette (Paderborn, DE)
Abstract Slides Video
Presentation thumbnail
Ablation outcome and post-interventional management of anticoagulation in patients with obesity or severe obesity and atrial fibrillation
Ms R. Bares (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Distribution of apixaban plasma concentrations across prescribed dose groups for ischemic stroke prevention in atrial fibrillation
Associate Professor K. Lim (Busan, KR)
Abstract Slides Video
Presentation thumbnail
CHA2DS2-VASc score-based anticoagulation management after catheter ablation for atrial fibrillation: a post-hoc analysis of the ALONE-AF trial
Doctor Y. Lee (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Oral anticoagulation in atrial fibrillation

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Efficacy, safety and very long term recurrences of cavo-tricuspid isthmus-dependent atrial flutter ablation: a large multicenter observational study.
thumbnail
Congress Presentation
Cavotricuspid isthmus ablation using a pentaspline pulsed field ablation catheter: one-year outcomes.
thumbnail
Congress Presentation
Pulmonary vein isolation with or without empirical cavotricuspid isthmus ablation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources